Unicycive Therapeutics, Inc (UNCY)
7.43
+0.23 (3.19%)
Upcoming Events
Latest Headlines
Unicycive Therapeutics (UNCY) PT Raised to $18 at Benchmark
June 2, 2026 8:07 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
May 27, 2026 6:50 AM - StreetInsider
Form 4 Unicycive Therapeutics, For: May 14 Filed by: Kenkare-Mitra Sara
May 21, 2026 4:31 PM - SEC Filing
Form 4 Unicycive Therapeutics, For: May 14 Filed by: Gupta Shalabh K.
May 21, 2026 4:30 PM - SEC Filing
Form 4 Unicycive Therapeutics, For: May 14 Filed by: Jermasek Douglas
May 20, 2026 4:31 PM - SEC Filing
Form 4 Unicycive Therapeutics, For: May 14 Filed by: Gupta Pramod
May 20, 2026 4:31 PM - SEC Filing
Form 4 Unicycive Therapeutics, For: May 14 Filed by: Townsend John
May 20, 2026 4:31 PM - SEC Filing
Form 4 Unicycive Therapeutics, For: May 14 Filed by: Laumas Sandeep
May 18, 2026 8:58 PM - SEC Filing
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 4:49 PM - SEC Filing
Unicycive Therapeutics (UNCY) PT Lowered to $37 at Guggenheim
May 13, 2026 6:38 AM - StreetInsider
Unicycive Therapeutics, Inc (UNCY) Misses Q1 EPS by 54c
May 12, 2026 8:05 AM - StreetInsider
Form 8-K Unicycive Therapeutics, For: May 12
May 12, 2026 7:52 AM - SEC Filing
Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026 7:05 AM - Globe NewsWire
Form 10-Q Unicycive Therapeutics, For: Mar 31
May 12, 2026 6:31 AM - SEC Filing
Form S-8 Unicycive Therapeutics,
May 6, 2026 6:06 AM - SEC Filing
B.Riley Starts Unicycive Therapeutics (UNCY) at Buy
May 1, 2026 9:17 AM - StreetInsider
Form ARS Unicycive Therapeutics, For: Dec 31
April 30, 2026 7:04 AM - SEC Filing
Form DEFA14A Unicycive Therapeutics,
April 30, 2026 7:02 AM - SEC Filing
Form DEF 14A Unicycive Therapeutics, For: Jun 19
April 30, 2026 7:00 AM - SEC Filing
Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
April 9, 2026 7:05 AM - Globe NewsWire
Unicycive Therapeutics (UNCY) PT Lowered to $23 at Brookline Capital Markets
April 7, 2026 4:31 PM - StreetInsider
Form 8-K Unicycive Therapeutics, For: Apr 06
April 6, 2026 9:12 AM - SEC Filing
Unicycive Therapeutics (UNCY) PT Lowered to $15 at Benchmark
April 6, 2026 7:21 AM - StreetInsider
Unicycive Therapeutics (UNCY) PT Lowered to $40 at Guggenheim
April 2, 2026 6:40 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
April 1, 2026 6:59 AM - StreetInsider
Form 8-K Unicycive Therapeutics, For: Mar 30
March 30, 2026 7:29 AM - SEC Filing
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
March 30, 2026 7:05 AM - Globe NewsWire
Form 10-K Unicycive Therapeutics, For: Dec 31
March 30, 2026 6:32 AM - SEC Filing
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDA
March 18, 2026 9:17 AM - Globe NewsWire
Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNC
March 16, 2026 9:32 AM - StreetInsider
Important Notice to Long-Term Shareholders of Integer Holdings Corp. (NYSE: ITGR): Molina Healthcare, Inc. (NYSE: MOH); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (N
March 12, 2026 8:15 AM - StreetInsider
Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc.
March 10, 2026 9:08 AM - Globe NewsWire
Full Article List
